<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font24">the </span>
   <span class="font20">COVID- </span>
   <span class="font17">with </span>
   <span class="font14">were </span>
   <span class="font14">for </span>
   <span class="font13">was </span>
   <span class="font13">The </span>
   <span class="font13">studies </span>
   <span class="font13">[]. </span>
   <span class="font13">case </span>
   <span class="font13">COVID-/TB </span>
   <span class="font12">cases </span>
   <span class="font12">HIV </span>
   <span class="font12">N/A </span>
   <span class="font12">co-infection </span>
   <span class="font12">HIV/TB </span>
   <span class="font12">study </span>
   <span class="font12">patients </span>
   <span class="font12">that </span>
   <span class="font12">not </span>
   <span class="font12">SARS-CoV </span>
   <span class="font12">included </span>
   <span class="font11">co-infected </span>
   <span class="font11">PTB </span>
   <span class="font11">reported </span>
   <span class="font11">COVID-/HIV/TB </span>
   <span class="font11">are </span>
   <span class="font11">should </span>
   <span class="font11">COVID-/HIV </span>
   <span class="font11">cohort </span>
   <span class="font11">may </span>
   <span class="font11">{background </span>
   <span class="font11">high </span>
   <span class="font11">risk </span>
   <span class="font11">series </span>
   <span class="font11">This </span>
   <span class="font11">associated </span>
   <span class="font11">burden </span>
   <span class="font11">from </span>
   <span class="font11">MERS-CoV </span>
   <span class="font11">coronavirus </span>
   <span class="font11">severe </span>
   <span class="font11">among </span>
   <span class="font11">China </span>
   <span class="font11">confirmed </span>
   <span class="font11">drugs </span>
   <span class="font11">mortality </span>
   <span class="font11">margin </span>
   <span class="font11">one </span>
   <span class="font11">tuberculosis </span>
   <span class="font11">countries </span>
   <span class="font11">interest </span>
   <span class="font11">{border-style </span>
   <span class="font10">had </span>
   <span class="font10">compared </span>
   <span class="font10">px;} </span>
   <span class="font10">rate </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">analysis </span>
   <span class="font10">between </span>
   <span class="font10">review </span>
   <span class="font10">two </span>
   <span class="font10">also </span>
   <span class="font10">disease </span>
   <span class="font10">have </span>
   <span class="font10">history </span>
   <span class="font10">management </span>
   <span class="font10">recovery </span>
   <span class="font10">three </span>
   <span class="font10">clinical </span>
   <span class="font10">interactions </span>
   <span class="font10">outcomes </span>
   <span class="font10">people </span>
   <span class="font10">respiratory </span>
   <span class="font10">therapy </span>
   <span class="font10">which </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Health </span>
   <span class="font10">USA </span>
   <span class="font10">after </span>
   <span class="font10">observational </span>
   <span class="font10">occurrence </span>
   <span class="font10">severe/critical </span>
   <span class="font10">than </span>
   <span class="font10">All </span>
   <span class="font10">SARS, </span>
   <span class="font10">Xpert </span>
   <span class="font10">[], </span>
   <span class="font10">active </span>
   <span class="font10">both </span>
   <span class="font10">data </span>
   <span class="font10">group </span>
   <span class="font10">outcome </span>
   <span class="font10">previous </span>
   <span class="font10">status </span>
   <span class="font10">Case </span>
   <span class="font10">MTB/RIF </span>
   <span class="font10">Previous </span>
   <span class="font10">TB, </span>
   <span class="font10">TB. </span>
   <span class="font10">conducted </span>
   <span class="font10">descriptive </span>
   <span class="font10">developed </span>
   <span class="font10">diagnosed </span>
   <span class="font10">diagnosis </span>
   <span class="font10">infection </span>
   <span class="font10">patient </span>
   <span class="font10">report </span>
   <span class="font10">severity </span>
   <span class="font10">â€‰years </span>
   <span class="font10">.collab: </span>
   <span class="font10">Pâ€‰ </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">TB: </span>
   <span class="font10">age </span>
   <span class="font10">al. </span>
   <span class="font10">based </span>
   <span class="font10">control </span>
   <span class="font10">during </span>
   <span class="font10">lung </span>
   <span class="font10">rifampicin </span>
   <span class="font10">treatment </span>
   <span class="font10">â€‰mg </span>
   <span class="font10">COVID-: </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">MERS </span>
   <span class="font10">drug </span>
   <span class="font10">four </span>
   <span class="font10">has </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">more </span>
   <span class="font10">other </span>
   <span class="font10">recovered </span>
   <span class="font10">results </span>
   <span class="font10">showed </span>
   <span class="font10">syndrome </span>
   <span class="font10">test </span>
   <span class="font10">them </span>
   <span class="font10">this </span>
   <span class="font10">those </span>
   <span class="font10">.â€"., </span>
   <span class="font10">AND </span>
   <span class="font10">Among </span>
   <span class="font10">Infect </span>
   <span class="font10">Med </span>
   <span class="font10">Three </span>
   <span class="font10">anti </span>
   <span class="font10">antiviral </span>
   <span class="font10">assay </span>
   <span class="font10">current </span>
   <span class="font10">described </span>
   <span class="font10">due </span>
   <span class="font10">evidence </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">includes </span>
   <span class="font10">infected </span>
   <span class="font10">old </span>
   <span class="font10">out </span>
   <span class="font10">pulmonary </span>
   <span class="font10">px; </span>
   <span class="font10">related </span>
   <span class="font10">screening </span>
   <span class="font10">significant </span>
   <span class="font10">systematic </span>
   <span class="font10">used </span>
   <span class="font10">{font-family </span>
   <span class="font10">Africa </span>
   <span class="font10">Anti-TB </span>
   <span class="font10">Both </span>
   <span class="font10">Fig. </span>
   <span class="font10">However, </span>
   <span class="font10">Meta-analysis </span>
   <span class="font10">SARS </span>
   <span class="font10">Severe </span>
   <span class="font10">South </span>
   <span class="font10">World </span>
   <span class="font10">acute </span>
   <span class="font10">administered </span>
   <span class="font10">adults </span>
   <span class="font10">algorithm </span>
   <span class="font10">all </span>
   <span class="font10">because </span>
   <span class="font10">cases. </span>
   <span class="font10">chest </span>
   <span class="font10">chloroquine </span>
   <span class="font10">co-infection. </span>
   <span class="font10">different </span>
   <span class="font10">eight </span>
   <span class="font10">fibrosis </span>
   <span class="font10">font-size </span>
   <span class="font10">guidelines </span>
   <span class="font10">living </span>
   <span class="font10">median </span>
   <span class="font10">new </span>
   <span class="font10">patients. </span>
   <span class="font10">sample </span>
   <span class="font10">such </span>
   <span class="font10">use </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(Fig.Â </span>
   <span class="font10">Cases </span>
   <span class="font10">Clinical </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Outcomes </span>
   <span class="font10">Retrospective </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Table </span>
   <span class="font10">Two </span>
   <span class="font10">University, </span>
   <span class="font10">Wang </span>
   <span class="font10">against </span>
   <span class="font10">and/or </span>
   <span class="font10">articles </span>
   <span class="font10">co-infections. </span>
   <span class="font10">co-infectionâ€� </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">design </span>
   <span class="font10">double; </span>
   <span class="font10">drug-drug </span>
   <span class="font10">epidemics </span>
   <span class="font10">important </span>
   <span class="font10">increase </span>
   <span class="font10">indicated </span>
   <span class="font10">indicated. </span>
   <span class="font10">known </span>
   <span class="font10">less </span>
   <span class="font10">major </span>
   <span class="font10">males </span>
   <span class="font10">medical </span>
   <span class="font10">published </span>
   <span class="font10">same </span>
   <span class="font10">six </span>
   <span class="font10">stages </span>
   <span class="font10">statistically </span>
   <span class="font10">strong </span>
   <span class="font10">subgroup </span>
   <span class="font10">symptoms </span>
   <span class="font10">well </span>
   <span class="font10">âˆ’ </span>
   <span class="font10">-year-old </span>
   <span class="font10">AIDS </span>
   <span class="font10">ART </span>
   <span class="font10">Anti </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Critical </span>
   <span class="font10">Current </span>
   <span class="font10">HIV, </span>
   <span class="font10">Had </span>
   <span class="font10">MDR-TB </span>
   <span class="font10">Not </span>
   <span class="font10">PRISMA </span>
   <span class="font10">RT-PCR </span>
   <span class="font10">Saudi </span>
   <span class="font10">any </span>
   <span class="font10">article </span>
   <span class="font10">assessed </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">co-infection: </span>
   <span class="font10">could </span>
   <span class="font10">course </span>
   <span class="font10">critical </span>
   <span class="font10">culture </span>
   <span class="font10">deaths </span>
   <span class="font10">dose </span>
   <span class="font10">estimated </span>
   <span class="font10">exposure </span>
   <span class="font10">first </span>
   <span class="font10">following </span>
   <span class="font10">form </span>
   <span class="font10">heterogeneity </span>
   <span class="font10">identified </span>
   <span class="font10">incidence </span>
   <span class="font10">increased </span>
   <span class="font10">induce </span>
   <span class="font10">inhibitors </span>
   <span class="font10">last </span>
   <span class="font10">likely </span>
   <span class="font10">low </span>
   <span class="font10">mean </span>
   <span class="font10">months </span>
   <span class="font10">number </span>
   <span class="font10">pandemics </span>
   <span class="font10">patients, </span>
   <span class="font10">poor </span>
   <span class="font10">prospective </span>
   <span class="font10">quality </span>
   <span class="font10">real-time </span>
   <span class="font10">recent </span>
   <span class="font10">seven </span>
   <span class="font10">short </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">support </span>
   <span class="font10">total </span>
   <span class="font10">undertaken </span>
   <span class="font10">versus </span>
   <span class="font10">viral </span>
   <span class="font10">without </span>
   <span class="font10">worldwide </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€‰days </span>
   <span class="font10">(two </span>
   <span class="font10">-Case </span>
   <span class="font10">COVID-/TB: </span>
   <span class="font10">Care </span>
   <span class="font10">Clin </span>
   <span class="font10">Disease </span>
   <span class="font10">East </span>
   <span class="font10">HIV- </span>
   <span class="font10">Health, </span>
   <span class="font10">Italy </span>
   <span class="font10">Latent </span>
   <span class="font10">NOS </span>
   <span class="font10">Option </span>
   <span class="font10">Outcome: </span>
   <span class="font10">Public </span>
   <span class="font10">Pâ€‰=â€‰. </span>
   <span class="font10">SARS-CoV. </span>
   <span class="font10">SARS-CoV/HIV/TB </span>
   <span class="font10">Sci </span>
   <span class="font10">Singapore, </span>
   <span class="font10">United </span>
   <span class="font10">Ventilatory </span>
   <span class="font10">across </span>
   <span class="font10">another </span>
   <span class="font10">anti-TB </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">can </span>
   <span class="font10">care </span>
   <span class="font10">case-control </span>
   <span class="font10">cases) </span>
   <span class="font10">challenges </span>
   <span class="font10">characteristics </span>
   <span class="font10">co-infections </span>
   <span class="font10">considerations </span>
   <span class="font10">considerations. </span>
   <span class="font10">considered </span>
   <span class="font10">continue </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">countries. </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">death </span>
   <span class="font10">development </span>
   <span class="font10">distribution </span>
   <span class="font10">done </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">fact, </span>
   <span class="font10">factors </span>
   <span class="font10">found </span>
   <span class="font10">further </span>
   <span class="font10">groups. </span>
   <span class="font10">higher </span>
   <span class="font10">hospitalization </span>
   <span class="font10">including </span>
   <span class="font10">latent </span>
   <span class="font10">lower </span>
   <span class="font10">managed </span>
   <span class="font10">management. </span>
   <span class="font10">mild </span>
   <span class="font10">moderate </span>
   <span class="font10">most </span>
   <span class="font10">newly </span>
   <span class="font10">once </span>
   <span class="font10">outcomes. </span>
   <span class="font10">pooled </span>
   <span class="font10">positive </span>
   <span class="font10">presented </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">publication </span>
   <span class="font10">research </span>
   <span class="font10">resistance </span>
   <span class="font10">result </span>
   <span class="font10">retrospective </span>
   <span class="font10">review. </span>
   <span class="font10">role </span>
   <span class="font10">safety </span>
   <span class="font10">search </span>
   <span class="font10">special </span>
   <span class="font10">spread </span>
   <span class="font10">start </span>
   <span class="font10">studies, </span>
   <span class="font10">sub-Saharan </span>
   <span class="font10">taken </span>
   <span class="font10">time </span>
   <span class="font10">unit </span>
   <span class="font10">virus </span>
   <span class="font10">while </span>
   <span class="font10">years </span>
  </p>
 </body>
</html>
